Lumos Pharma, Inc. (LUMO) Updated Phase 2 OraGrowtH Data Presented at ESPE 2024 Demonstrate Sustained Growth on Oral LUM-201 to 24 Months Nov 21, 2024 09:01AM
Jones Trading Downgrades Lumos Pharma (LUMO) to Hold Oct 23, 2024 10:20AM
Lumos Pharma (LUMO) Enters Pact with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus CVR Oct 23, 2024 08:01AM
Lumos Pharma, Inc. (LUMO) Halted, News Pending Oct 23, 2024 07:55AM
H.C. Wainwright Reiterates Buy Rating on Lumos Pharma (LUMO) Sep 30, 2024 07:28AM


Sep 24, 2024 07:02AM EF Hutton Starts Lumos Pharma (LUMO) at Buy
Aug 1, 2024 04:51PM Lumos Pharma, Inc. (LUMO) Tops Q2 EPS by 24c